Tuesday, January 25, 2022


Bharat Biotech recruits 23k volunteers for COVID-19 vaccine trials

Covaxin is being developed by Bharat Biotech jointly with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV).

India approves 2 Covid vaccines for emergency use

This is a major relief for India which has the second highest number of infections in the world, after the US. The Central government plans to vaccinate nearly 30 crore people in the first phase of drive in the next six to eight months.

Expert panel recommends Bharat Biotech’s ‘Covaxin’ for emergency use

The final decision on its approval will, however, be taken by the Drug Controller General of India (DCGI)

Expert panel clears Covishield vaccine’s emergency use in India

The application will be sent to Drugs Controller General of India (DCGI) V.G. Somani for final approval

US-based Ocugen, Bharat Biotech collaborate

Companies to co-develop Covaxin to prevent Covid-19 infection in the US

Bharat Biotech recruits 13,000 subjects for Covaxin Phase-3 trials

Trials that began during mid-November are targeted to be done in 26,000 volunteers across multiple sites in India

70 Ambassadors visit Bharat Biotech facility

The project update on Covaxin was presented to the delegates by Dr Krishna Ella, chairman and managing director, Bharat Biotech.

Envoys of 64 countries visit Covid vaccine makers in Hyderabad

The visit by the heads of foreign missions was organised by the Ministry of External Affairs (MEA) and was part of India's efforts to develop partnerships for the manufacture and delivery of vaccines

AI can help add $957 billion to Indian economy by 2035: Kant

In a session titled ‘Transformation of India with a focus on the entrepreneur ecosystem’ Kant said that India has grown as a technology country.

Government, Bharat Biotech clarify after Haryana Minister tests positive

Bharat Biotech stated it is an innovator, vaccine developer and manufacturer and safety of vaccines is its primary objective, followed by efficacy

‘Covaxin a 2-dose anti-coronavirus vaccine, Anil Vij got only 1st dose’

The 67-year-old minister was given the first shot on November 20.

Haryana Minister tests COVID positive weeks after getting trial dose of vaccine

The 67-year-old is a senior leader of the ruling Bharatiya Janata Party (BJP) and a legislator from Ambala Cantt assembly constituency.

Phase-3 clinical trial of Covaxin commences in Kolkata

West Bengal Governor Jagdeep Dhankhar said NICED has been chosen as one among two dozen centres in the country for the third phase trial of the indigenously developed coronavirus vaccine.

GHMC polls: Campaigning hits crescendo

Hyderabad: The Greater Hyderabad Municipal Corporation election is turning out to be the mother of all polls, for the sheer political heat it has...

KCR conspiring against PM’s Covid vaccine initiative: Bandi

BJP leader remained mum on the State govt's demand that vaccine from Hyderabad-based pharma major should first be released to the people of the State

Latest News

- Advertisement -